contact info sitemap
  torrent story milestones business areas group companies social responsibility news & media careers
 
  Torrent email us Torrent Group home  
 
  Torrent Pharmaceutical Limited  
  Rest of the World...
 
     
   
Company Overview
Domestic
Marketing Operations
International
Marketing Operations
...Latin America ...
...Russian & CIS...
...Europe ...
...Rest of the World...
 
R & D Center
Manufacturing Plant
Management
Financials
Therapeutic Index
Contacts
 
Torrent's consistently strong sales growth
over the past decade displays the confidence
of customers in the
Torrent brand
 

This zone takes in its broad sweep 30 different countries in South East Asia, Asia Pacific, Africa & Middle East regions. Torrent’s core strategy in these markets is to shift from a trading-based business model to one that is marketing-based. The endeavor is to galvanize sales by building existing brands and generate new opportunities by introducing new products.

Africa
Torrent’s pharma ambitions in this zone are as vast as the continent. With 355 product registrations across 14 countries and a promising products registration pipeline, Torrent is confident about registering a bigger presence in the years to come.

Torrent’s focal areas of operations in Africa :

Uganda
Nigeria
Ghana
South Africa

Asia
The continent is starting to occupy a bigger place in Torrent’s scheme of things. The Company is exploring possibilities over a vast geographical spread that stretches from Singapore, Malaysia, Thailand, Philippines, Indonesia, Myanmar and Vietnam in eastern Asia to Yemen, Bahrain, Oman, UAE and Saudi Arabia in the middle-east and Sri Lanka in South Asia. Plans are also afoot to enter high potential markets like Australia, New Zealand, China, South Korea and Taiwan.

Torrent’s operational hubs in Asia

Sri Lanka
Vietnam
Myanmar
Middle East

Zimbabwe
Torrent has the distinction of being one of the first Indian companies to get its products registered here. With a strong portfolio of 34 products and a pipeline of 11 products awaiting registration, it leads the pack of Indian companies here.

:: Zimbabwe ::

Contact person : Mr. Ghanshyam Jha

Distributor :
C/O. Mr. Dhansukh Shah
Pharmaceuticals and Chemicals
Distributors (P) Ltd.
1st Floor, Tagore House,
50 Cameroon StreetHarare,
Zimbabwe

E-mail :

Kenya
This gateway to East African markets has great strategic significance. Starting its marketing operations in 1994, Torrent today has 45 active product registrations with 10 more in the offing.

:: Kenya ::

Contact person : Mr. Sunil Kumar

Distributor :
Medox Pharmaceuticals Ltd.
Hazina Towers,
Ground Floor, P.O. Box- 52771
Nairobi, Kenya

E-mail :

Uganda
Torrent’s products have found wide acceptance amongst the medical fraternity here. The strategic thrust will continue to be cardiovascular and CNS segments, Torrent’s forte over the years. There are 28 products from the Torrent stable, with 12 more seeking registration.

Nigeria
One of West Africa’s biggest market, Nigeria, will be Torrent’s launch pad for its foray into other markets of the region. With a handful of registrations under its belt and some more pending approval, Torrent is well placed to begin a new chapter in the region.

Ghana
Ghana is one of Torrent’s mature markets in the region, with a portfolio of 20 products, 5 more pending registration, and it’s Ciprofloxacin (Quintor) and Ceftriaxone (Torocef) brands among the frontrunners in Ghana.

:: Ghana ::

Contact person : Mr. Nitin Mehrotra

Distributor :
C/o Gokals Ltd.
D 509/3, Zongo Lane,
P.O. Box 623,

E-mail :

South Africa
South Africa MCC stamp of approval for Torrent’s manufacturing facility is the key to opening up Africa’s biggest and most regulated markets. Apart from its normal range of products, the Company has ambitious plans to offer its developmental products in this evolved market.

India

:: India ::
Contact Person : Mr. Nirav jhaveri
Mr. C.V.S.S Prasad
Mr. Harjeet Singh

Address :
Torrent Pharmaceuticals Ltd,
International Operations Division,
4th Floor, Torrent Tower,
Off. Ashram Road
Ahmedabad : 380 009.

Phone : +91-79-2658 5090 /2070
Fax : +91-79-2657 4491

Email :

Sri Lanka
With a portfolio of over 60 products and a pipeline of another 30, Torrent is a well-accepted brand here. Its neuropsychiatry, cardiovascular and gastro range has fetched the Company consistent turnover gains over the years. The anti epileptic Valparin and anti alcoholic Esperal are brand leaders. The State Pharmaceutical Corporation has selected Torrent as ‘Best Supplier’ in 2001-02 for its quality and commitment to delivery schedules.

:: Srilanka ::

Contact person : Mr. Vinod Hegde

Phone : 0094777731616

E-mail :

Vietnam
Staring operations in 1996, Torrent quickly began establishing itself, especially in cardiology and neuropsychiatry. The leading brands in these therapeutic areas include Amlocor, Toraass, Valparin, Respidon and Crabatol. The Company created history by launching a new molecule, Nicorandil (Nikoran), and emulated the feat of western originators who are the ones used to doing such things. By 2006-07, Torrent expects to be among the top three Indian pharma companies operating from Vietnam.

:: Vietnam ::

Contact person : Mr.Manoj Barthwal

Address :
Torrent Pharmaceuticals Ltd.
Asean House, 2nd Floor
56A, Nguyen Thong St. Ward 9
District 3, Ho Chi Minh City
Vietnam

Phone :
+84-8-931 8757, 931 8758
Fax : +84-8-931 8759

E-mail :

Myanmar
After operations started in 1995, Myanmar rapidly became one of Torrent’s strongholds. With 44 products registrations, another 18 in the pipeline, strong presence in cardiovascular and neuro-psychotics, Torrent is ready to create a specialty product platform. Calcigard , Ranitin and Lamitor are already the top market grossers.

:: Myanmar ::

Contact person : Mr.Sandeep Gemini

Phone : 009595005456

E-mail :

Philippines
Torrent’s Philippines venture, its first subsidiary in Asia, was started to capitalize on the ample opportunities this densely populated island offers. From mere trading, the strategic endeavor has been to switch to a more aggressive marketing mode, build brands for greater penetration.

:: Philippines ::

Contact person : Mr.Chakravarthy M.S.

Phone : 00639277134630

E-mail :

Middle East
Currently, Yemen and Bahrain represent Torrent’s major interests in the region. Both together account for 30 product registrations and a significant pipeline. Both have also shown high revenue growths, with brands like HB Plus, Omizac, Domstal and Quintor being the most impressive performers. To leverage the potential such high growth represents, Torrent is looking at a host of options, including marketing tie-ups, in places like Oman, UAE, Kuwait, etc.

India
:: India ::
Contact Person : Mr. Sarthak Vasudeva
Mr. Rajeev Nanda
Mr. Samrat Choudhury
Mr. Harjeet Singh

Address :
4th Floor, Torrent Tower
Off. Ashram Road
Ahmedabad : 380 009.

Phone : +91-79-2658 5090 /2070
Fax : +91-79-2657 4491

Email :


     
 
home email us copy right 2004 Torrent Group   contact info sitemap go to top